Anterios
Latest round
- Series B
Last raised
- Mar 2013
Total raised
- $17M
Investors
- 3
About Anterios
Anterios, founded in 2006 and headquartered in New York, US, is a biotechnology company that specializes in developing treatments for complex medical conditions. The firm has undergone a significant transition, being acquired by Allergan Inc.00 mn. The acquisition marked a pivotal moment in the company's evolution, allowing for enhanced resources and research capabilities. Anterios has been involved in a total of 8 deals, reflecting its active engagement in the biotechnology sector.Anterios is dedicated to the development of innovative biopharmaceutical solutions for complex diseases. Its product portfolio includes biologics and therapies targeting conditions such as rheumatoid arthritis and various forms of cancer, focusing on enhancing patient outcomes through advanced therapeutic interventions.Anterios generates revenue primarily through the sale of its biotechnology products, which are marketed to healthcare providers and specialty pharmacies. The pricing for these products is based on negotiated contracts reflecting the therapeutic value provided to patients.00 mn to expedite the development of new biopharmaceutical products and expand its market presence. The company aims to launch new therapies targeting additional complex diseases in the coming years, with plans to enter international markets in Europe and Asia-Pacific by 2024, enhancing its global reach and accessibility.
Who invested in Anterios
3 investors across 3 rounds
See all investors in Anterios
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Anterios
Who invested in Anterios?
Anterios has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anterios raised?
Anterios has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Anterios last raise money?
Anterios's most recent round on record is a Series B, in Mar 2013.
What does Anterios do?
Anterios, founded in 2006 and headquartered in New York, US, is a biotechnology company that specializes in developing treatments for complex medical conditions.
Where is Anterios headquartered?
Anterios is headquartered in New York, US.
Which VCs invest in companies like Anterios?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Anterios's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Anterios? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.